94 related articles for article (PubMed ID: 8112036)
1. Interpretive criteria for cefodizime in vitro susceptibility tests with Neisseria gonorrhoeae.
Barrett MS; Jones RN; Erwin ME
Diagn Microbiol Infect Dis; 1993 Oct; 17(3):243-5. PubMed ID: 8112036
[TBL] [Abstract][Full Text] [Related]
2. Development of Neisseria gonorrhoeae in vitro susceptibility test methods for cefixime including quality control guidelines.
Jones RN; Gerlach EH; Koontz FP; Murray PR; Pfaller MA; Washington JA; Erwin ME; Knapp CC
Diagn Microbiol Infect Dis; 1991; 14(5):383-8. PubMed ID: 1797455
[TBL] [Abstract][Full Text] [Related]
3. Susceptibility testing interpretive criteria and drug stability for cefdinir, cefetamet, and cefpodoxime against Neisseria gonorrhoeae.
Barrett MS; Jones RN
Diagn Microbiol Infect Dis; 1992; 15(8):685-91. PubMed ID: 1478049
[TBL] [Abstract][Full Text] [Related]
4. In vitro comparison of disk diffusion and agar dilution antibiotic susceptibility test methods for Neisseria gonorrhoeae.
de Castillo MC; de Saab OA; de Nader OM; de Ruiz Holgado AP
Mem Inst Oswaldo Cruz; 1998; 93(4):517-22. PubMed ID: 9711344
[TBL] [Abstract][Full Text] [Related]
5. Interpretive criteria, quality control guidelines, and drug stability studies for susceptibility testing of cefotaxime, cefoxitin, ceftazidime, and cefuroxime against Neisseria gonorrhoeae.
Jones RN; Fuchs PC; Washington JA; Gavan TL; Murray PR; Gerlach EH; Thornsberry C
Diagn Microbiol Infect Dis; 1990; 13(6):499-507. PubMed ID: 2126232
[TBL] [Abstract][Full Text] [Related]
6. Interpretive criteria for susceptibility testing of CI-960 (PD127391, AM-1091), fleroxacin, lomefloxacin, and temafloxacin against Neisseria gonorrhoeae, including drug stability in GC agar medium.
Erwin ME; Jones RN
J Clin Microbiol; 1992 May; 30(5):1170-3. PubMed ID: 1316366
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of interpretive criteria of agar dilution and disk diffusion susceptibility tests for Neisseria gonorrhoeae.
Altaie SS; Moore LS; Dryja D; Furness K
Diagn Microbiol Infect Dis; 1994 Mar; 18(3):175-80. PubMed ID: 7924210
[TBL] [Abstract][Full Text] [Related]
8. Comparative in vitro activity of cefodizime, ceftazidime, aztreonam, and other selected antimicrobial agents against Neisseria gonorrhoeae.
Khan MY; Gruninger RP; Nelson SM; Obaid SR
Antimicrob Agents Chemother; 1983 Mar; 23(3):477-8. PubMed ID: 6303215
[TBL] [Abstract][Full Text] [Related]
9. Ceftizoxime interpretive criteria for in vitro susceptibility tests with Neisseria gonorrhoeae.
Barrett MS; Jones RN; Erwin ME
J Clin Microbiol; 1993 Sep; 31(9):2531-2. PubMed ID: 8408583
[TBL] [Abstract][Full Text] [Related]
10. Interpretive criteria for susceptibility tests with DU-6859a and FK-037 tested against Haemophilus influenzae and Neisseria gonorrhoeae.
Jones RN; Barrett MS; Biedenbach DJ
Diagn Microbiol Infect Dis; 1994 Jun; 19(2):93-9. PubMed ID: 7805362
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the standardized disk diffusion and agar dilution antibiotic susceptibility test methods by using strains of Neisseria gonorrhoeae from the United States and Southeast Asia.
Putnam SD; Lavin BS; Stone JR; Oldfield EC; Hooper DG
J Clin Microbiol; 1992 Apr; 30(4):974-80. PubMed ID: 1572986
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the standardized disk diffusion and agar dilution antibiotic susceptibility test methods by using strains of Neisseria gonorrhoeae from Tucumán, Argentina.
de Castillo MC; de Saab OA; de Nader OM; de Ruiz Holgado AP
Biol Pharm Bull; 1997 Sep; 20(9):1010-2. PubMed ID: 9331987
[TBL] [Abstract][Full Text] [Related]
13. Interpretive criteria and quality control guidelines for Neisseria gonorrhoeae susceptibility test standardization for cefotetan.
Jones RN; Gerlach EH; Koontz FP; Murray PR; Pfaller MA; Washington JA; Erwin ME; Knapp CC
J Clin Microbiol; 1991 Feb; 29(2):363-6. PubMed ID: 1901067
[TBL] [Abstract][Full Text] [Related]
14. In vitro antibacterial activity and beta-lactamase stability of cefodizime, a new cephalosporin antibiotic.
Kasai K; Tsuji A; Miyazaki S; Goto S; Fujimoto K; Masuyoshi S; Arai S
Jpn J Antibiot; 1984 Jul; 37(7):1294-305. PubMed ID: 6092739
[TBL] [Abstract][Full Text] [Related]
15. Susceptibility of Neisseria gonorrhoeae to ceftizoxime in vitro and in vivo.
Korting HC; Neubert U
Chemotherapy; 1984; 30(5):322-7. PubMed ID: 6092006
[TBL] [Abstract][Full Text] [Related]
16. Neisseria gonorrhoeae strains isolated in Hong Kong: in vitro susceptibility to 13 antibiotics.
Ng WS; Anton P; Arnold K
Antimicrob Agents Chemother; 1981 Jan; 19(1):12-7. PubMed ID: 6787976
[TBL] [Abstract][Full Text] [Related]
17. Proposed interpretive criteria and quality control parameters for ofloxacin susceptibility testing of Neisseria gonorrhoeae.
Fuchs PC; Barry AL; Baker C; Murray PR; Washington JA
J Clin Microbiol; 1992 Apr; 30(4):1024-6. PubMed ID: 1572960
[TBL] [Abstract][Full Text] [Related]
18. [In vitro activity of a new 3d-generation cephalosporin, cefodizime, on hospital bacteria].
Soussy CJ; Otterbein G; Le Van Thoi J; Duval J; Chanal M; Cluzel M; Sirot D
Pathol Biol (Paris); 1986 Jun; 34(5 Pt 2):561-6. PubMed ID: 3534743
[TBL] [Abstract][Full Text] [Related]
19. Comparative in vitro activity of cefmenoxime, cefotaxime, cefuroxime, cefoxitin, and penicillin against Neisseria gonorrhoeae.
Khan MY; Siddiqui Y; Simpson ML; Gruninger RP
Antimicrob Agents Chemother; 1981 Nov; 20(5):681-2. PubMed ID: 6275781
[TBL] [Abstract][Full Text] [Related]
20. Susceptibility pattern of Neisseria gonorrhoeae to antimicrobial agents in Dar es Salaam.
Mbwana J; Mhalu F; Mwakagile D; Masesa J; Moshiro C; Sandstrom E
East Afr Med J; 1999 Jun; 76(6):330-4. PubMed ID: 10750520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
